{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:49:33Z","timestamp":1792172973350,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ahj.2017.12.021","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:07:07Z","timestamp":1518566827000},"page":"130-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril\/Valsartan Therapy for Heart Failure (PROVE-HF)"],"prefix":"10.1016","volume":"199","author":[{"given":"James L.","family":"Januzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Fombu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Maisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"McCague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana L.","family":"Pi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret F.","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome B.","family":"Riebman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ahj.2017.12.021_bb0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2017.12.021_bb0010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamacardio.2016.1724","article-title":"Potential mortality reduction with optimal implementation of angiotensin receptor neprilysin inhibitor therapy in heart failure","volume":"1","author":"Fonarow","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2017.12.021_bb0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejim.2012.11.015","article-title":"Long term health care consumption and cost expenditure in systolic heart failure","volume":"24","author":"Mejhert","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.ahj.2017.12.021_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejcnurse.2010.10.003","article-title":"Social status, health-related quality of life, and event-free survival in patients with heart failure","volume":"11","author":"Heo","year":"2012","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"2","key":"10.1016\/j.ahj.2017.12.021_bb0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cardfail.2009.08.010","article-title":"Patients' self-assessed functional status in heart failure by New York Heart Association class: a prognostic predictor of hospitalizations, quality of life and death","volume":"16","author":"Holland","year":"2010","journal-title":"J Card Fail"},{"issue":"16","key":"10.1016\/j.ahj.2017.12.021_bb0030","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahj.2017.12.021_bb0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.carpath.2011.11.007","article-title":"The pathophysiology of heart failure","volume":"21","author":"Kemp","year":"2012","journal-title":"Cardiovasc Pathol"},{"issue":"1","key":"10.1016\/j.ahj.2017.12.021_bb0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","article-title":"Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment","volume":"4","author":"Konstam","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ahj.2017.12.021_bb0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/01.CIR.89.1.68","article-title":"Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril","volume":"89","author":"St. John Sutton","year":"1994","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2017.12.021_bb0050","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/eurjhf\/hfs180","article-title":"Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study","volume":"15","author":"Weiner","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"10.1016\/j.ahj.2017.12.021_bb0055","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction","volume":"58","author":"Januzzi","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2017.12.021_bb0060","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1373\/clinchem.2006.069575","article-title":"Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data","volume":"52","author":"Masson","year":"2006","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.ahj.2017.12.021_bb0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/chf.12016","volume":"19","author":"Gaggin","year":"2013","journal-title":"Congest Heart Fail"},{"issue":"3","key":"10.1016\/j.ahj.2017.12.021_bb0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12265-015-9618-4","article-title":"Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure","volume":"8","author":"Motiwala","year":"2015","journal-title":"J Cardiovasc Transl Res"},{"issue":"3","key":"10.1016\/j.ahj.2017.12.021_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.ahj.2017.12.021_bb0080","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jacc.2015.01.033","article-title":"The path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failure","volume":"65","author":"Braunwald","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2017.12.021_bb0085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure","volume":"131","author":"Packer","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2017.12.021_bb0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cardfail.2014.10.014","article-title":"ST2 pathogenetic profile in ambulatory heart failure patients","volume":"21","author":"Bayes-Genis","year":"2015","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.ahj.2017.12.021_bb0095","first-page":"33","article-title":"High-sensitivity troponin T is detectable in most patients with clinically stable heart failure","volume":"21","author":"Lyons","year":"2014","journal-title":"Br J Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2017.12.021_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002551","article-title":"Plasma biomarkers reflecting profibrotic processes in heart failure with a preserved ejection fraction: data from the prospective comparison of ARNI with ARB on management of heart failure with preserved ejection fraction study","volume":"9","author":"Zile","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.ahj.2017.12.021_bb0105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2459\/JCM.0b013e328353128c","article-title":"B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF","volume":"13","author":"Ambrosy","year":"2012","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"6","key":"10.1016\/j.ahj.2017.12.021_bb0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.109.934471","article-title":"Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)","volume":"122","author":"Fonarow","year":"2010","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ahj.2017.12.021_bb0115","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ahj.2017.12.021_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000399","article-title":"Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening","volume":"2","author":"Xanthakis","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"23","key":"10.1016\/j.ahj.2017.12.021_bb0125","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","article-title":"Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction","volume":"106","author":"Weinberg","year":"2002","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2017.12.021_bb0130","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehn206","article-title":"Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction","volume":"29","author":"Kasama","year":"2008","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ahj.2017.12.021_bb0135","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1540-8159.2010.02723.x","article-title":"Adrenomedullin plasma levels predict left ventricular reverse remodeling after cardiac resynchronization therapy","volume":"33","author":"Morales","year":"2010","journal-title":"Pacing Clin Electrophysiol"},{"issue":"7","key":"10.1016\/j.ahj.2017.12.021_bb0140","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"van Heerebeek","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahj.2017.12.021_bb0145","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2017.12.021_bb0150","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ahj.2017.12.021_bb0155","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jchf.2016.03.012","article-title":"The importance of worsening heart failure in ambulatory patients: definition, characteristics, and effects of amino-terminal pro-b-type natriuretic peptide guided therapy","volume":"4","author":"Mallick","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.ahj.2017.12.021_bb0160","first-page":"86","article-title":"Treatment of heart failure in African Americans\u2014a call to action","volume":"103","author":"Mitchell","year":"2011","journal-title":"J Natl Med Assoc"},{"issue":"22","key":"10.1016\/j.ahj.2017.12.021_bb0165","doi-asserted-by":"crossref","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","article-title":"Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association","volume":"135","author":"Chow","year":"2017","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318300498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318300498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T19:07:15Z","timestamp":1725044835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318300498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":33,"alternative-id":["S0002870318300498"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.12.021","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril\/Valsartan Therapy for Heart Failure (PROVE-HF)","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}